Skip to main content

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
137,000
Value
$3.47M
% of portfolio
0.1%
Quarters held
2
Since Q3 2024
Holdings of ACAD by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026137,000$3.47M0.1%+137,000NewHolders
Q4 20240$00.0%−764,600−100.0%Sold outHolders
Q3 2024764,600$11.8M0.2%+764,600NewHolders